top of page
ATHENA
BEVACIZUMAB PLUS CHEMOTHERAPY IN LOCALLY RECURRENT OR METASTATIC BREAST CANCER
CLINICAL TRIAL DETAILS
BEVACIZUMAB PLUS CHEMOTHERAPY IN LOCALLY RECURRENT OR METASTATIC BREAST CANCER.
-
COUNTRY
STATUS
TUMOR TYPE
PHASE
N
SITES
BREAST
15
120.0
II
Spain
SETUP
PRESS RELEASE
SCIENTIFIC IMPACT
-
BLOG ARTICLES RELATED
-
TRIAL SITES
-
bottom of page